Dynamic Technology Lab’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Dynamic Technology Lab’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,269	Closed	-$57K	–	1562
2021 Q3	$57K	Sell	1,269 -36	-3%	-$1.76K	0.01%	998
2021 Q2	$71K	Buy	+1,305	New	+$77.2K	0.01%	1059
2020 Q3	–	Sell	-1,228	Closed	-$131K	–	1410
2020 Q2	$131K	Buy	+1,228	New	+$110K	0.02%	863
2018 Q3	–	Sell	-1,730	Closed	-$177K	–	1413
2018 Q2	$177K	Buy	+1,730	New	+$214K	0.03%	868

Other funds holding SYRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dynamic Technology Lab's SYRS Position: Q4 2021 in Review

Dynamic Technology Lab sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q4 2021, closing a stake of 1,269 shares — an estimated $57K sold.

Dynamic Technology Lab first reported a position in SYRS in Q2 2018 and held it in 4 quarters. The position peaked at $177K in Q2 2018. 90 funds tracked by Wall St. Rank hold SYRS as of Q4 2021.

Dynamic Technology Lab reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Dynamic Technology Lab sold 1,269 Syros Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $57K.
Dynamic Technology Lab first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
Dynamic Technology Lab's Syros Pharmaceuticals, Inc. Common Stock position peaked at $177K in Q2 2018.
90 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Dynamic Technology Lab's 13F filing for Q4 2021, filed 14 Feb 2022.